A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement*. Issue 5 (21st February 2022)

• Record Type: Journal Article
• Authors: Kiser, Stephanie B.; Sciacca, Kate; Jain, Nelia; Leiter, Richard; Mazzola, Emanuele; Gelfand, Samantha; Jehle, Jonathan; Bernacki, Rachelle; Lamas, Daniela; Cooper, Zara; Lakin, Joshua R.
• Is Part Of: Critical care medicine. Volume 50:Issue 5(2022)
• Page Start: 819
• Page End: 824
• Publication Date: 2022-02-21
• Subjects: critical care outcomes -- gastrostomy -- severe acute respiratory syndrome coronavirus 2 infection -- tracheostomy; Critical care medicine -- Periodicals; Soins intensifs -- Périodiques; 616.028
• DOI: 10.1097/CCM.0000000000005451
• Languages: English
• ISSNs: 0090-3493

Abstract

Abstract : OBJECTIVES: To determine the 30- and 90-day outcomes of COVID-19 patients receiving tracheostomy and percutaneous endoscopic gastrostomy (PEG). DESIGN: Retrospective observational study. SETTING: Multisite, inpatient. PATIENTS: Hospitalized COVID-19 patients who received tracheostomy and PEG at four Boston hospitals. INTERVENTIONS: Tracheostomy and PEG placement. MEASUREMENTS AND MAIN RESULTS: The primary outcome was mortality at 30 and 90 days post-procedure. Secondary outcomes included continued device presence, place of residence, complications, and rehospitalizations. Eighty-one COVID-19 patients with tracheostomy and PEG placement were included. At 90 days post-device placement, the mortality rate was 9.9%, 2.7% still had the tracheostomy, 32.9% still had the PEG, and 58.9% were at home. CONCLUSIONS: More than nine-in-10 patients in our population of COVID-19 patients who underwent tracheostomy and PEG were alive 90 days later and most were living at home. This study provides new information regarding the outcomes of this patient population that may serve as a step in guiding clinicians, patients, and families when making decisions regarding these devices.